Clinical trials: Metal Hip Replacement
Osteoarthritis
A Comparison of an Advanced Metal Hip System to a Resurfacing Hip System
The primary purpose of the current study is to investigate if the CONSERVE® A-Class Total Hip with BFH technology will lead to lower blood ion levels in patients, as compared to patients in a recent study who received the…
- Trial name
- NCT00380549
- Testing
- Blood ion levels
- Where
- Canada
- Volunteers
- 20 people
- Sponsor
- Ottawa Hospital Research Institute
Adverse Local Tissue Reaction, Total Hip Arthroplasty
ASR-XL Metal-on-Metal 522 Post-Market Surveillance Study
The purpose of this clinical study is to evaluate blood metal ion levels as a function of time of implantation for the ASR-XL MoM system.
- Trial name
- NCT01884532
- Testing
- ASR-XL Metal-on-Metal
- Where
- 7 sites in United States
- Volunteers
- 146 people
- Sponsor
- DePuy Orthopaedics
Osteoarthritis
Metal Ion Serum Concentrations in Patients With Total Hip Replacements
Other research studies have shown that the levels of metals in the blood are slightly increased after patients receive a total hip replacement.
- Trial name
- NCT00156598
- Volunteers
- 5 people, healthy volunteers welcome
- Sponsor
- The University of Texas Health Science Center at San Antonio
Indications for a Total Hip Prosthesis
Primary Ceramic-on-Ceramic Total Hip Replacement Versus Metal-on-Metal Hip Resurfacing in Young Active Patients
Comparison of the functional result and speed of rehabilitation between two types of hip prostheses: primary ceramic-on-ceramic total hip replacement versus metal-on-metal hip resurfacing.
- Trial name
- NCT00285129
- Testing
- ceramic-on-ceramic total hip replacement versus metal-on-metal hip resurfacing
- Where
- Belgium
- Volunteers
- 400 people
- Sponsor
- University Hospital, Ghent